Impact Biomedical Inc. (IBO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Impact Biomedical Inc. (IBO:NYSE), powered by AI.

Current Price
$0.55
Sector
Healthcare
What is the Impact Biomedical Inc. stock price forecast?

Impact Biomedical Inc. is currently trading at $0.55. View real-time AI analysis on Alpha Lenz.

What is Impact Biomedical Inc. insider trading activity?

View the latest insider trading data for Impact Biomedical Inc. on Alpha Lenz.

What is Impact Biomedical Inc.'s P/E ratio?

View Impact Biomedical Inc.'s valuation metrics on Alpha Lenz.

Impact Biomedical Inc.

NYSE · IBO
$0.55-0.01(-1.14%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Impact Biomedical Inc.'s future dividend policy...
Alpha Chat Insight

Impact Biomedical Inc.'s ROE is -140.4%. Explore profitability and growth together.

Ask for details

Company Overview

Impact Biomedical Inc. is a pioneering company within the biotechnology sector, focused on developing innovative solutions that address key challenges in health and wellness. The primary function of Impact Biomedical Inc. is to research and create cutting-edge biotechnologies that have the potential to significantly impact pharmaceuticals, cosmetics, and other health-related industries. Notable features of the company include its strong emphasis on developing anti-pathogenic compounds, next-generation health supplements, and immunotherapy treatments. Impact Biomedical collaborates with research institutions and global partners to leverage scientific advancements and bring novel products to the market. As a player in the biotech market, Impact Biomedical Inc. plays a crucial role in advancing medical science and providing tools that combat health threats, contributing to the overall development and enhancement of public health solutions. Its innovations are particularly significant as they promise improvements in treatment efficacy and accessibility, thereby influencing various sectors aligned with health and disease prevention.

CEOMr. Frank D. Heuszel Esq., J.D.
SectorHealthcare
IndustryBiotechnology
Employees2

Company Statistics

FY 2025

Profile

N/AMarket Cap
$32.00KRevenue
0.00Shares Out
2Employees

Margins

-1225.00%Gross
-39062.50%EBITDA
-13343.75%Operating
-45156.25%Pre-Tax
-37093.75%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-13.82%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-62.98%ROA
-140.36%ROE
-72.46%ROIC

Financial Health

$3.00KCash & Cash Equivalents
$1.85MNet Debt
11.89%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Impact Biomedical Inc. (ticker: IBO) is a company listed on NYSE in the Healthcare sector (Biotechnology). It has approximately 2 employees.

The current price is $0.546 with a P/E ratio of -x and P/B of -x.

ROE is -140.36% and operating margin is -13343.75%. Annual revenue is $32,000.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Impact Biomedical Inc. (IBO) Stock Forecast 2026 $0.55 — Price, Financials & Analyst Targets | Alpha Lenz